Drug Shortage Report for MINT-OLANZAPINE

Last updated on 2020-10-27 History
Report ID 122524
Drug Identification Number 02410168
Brand name MINT-OLANZAPINE
Common or Proper name Olanzapine
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 count bottles
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-08-19
Actual start date
Estimated end date 2020-09-30
Actual end date 2020-10-26
Shortage status Resolved
Updated date 2020-10-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-10-27 French Compare
v6 2020-10-27 English Compare
v5 2020-09-21 French Compare
v4 2020-09-21 English Compare
v3 2020-08-20 English Compare
v2 2020-08-19 French Compare
v1 2020-08-19 English Compare

Showing 1 to 7 of 7